Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.

BACKGROUND The cytopathologic description of atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS) includes nine different criteria in The Bethesda System, and the risk of malignancy in this category shows a wide range. The objectives of the present study were to determine whether ultrasound (US)-guided core-needle biopsy (CNB) indicates a different malignant risk, and to identify management recommendations, malignant US findings, and distribution of CNB readings in subcategories of AUS/FLUS category, as seen on previous thyroid fine-needle aspiration readings. METHODS From October 2008 to July 2011, 191 thyroid nodules of 191 patients who had previously been diagnosed with nuclear atypia (Group AUS; n=84) and microfollicular architecture (Group FLUS; n=107) were enrolled in our retrospective study. Final diagnoses were obtained in 142 nodules after surgery and clinico-radiological follow-up. We compared the malignancy risk, management recommendation, malignant US findings, and distribution of CNB readings between the two groups and calculated the diagnostic value of CNB. RESULTS With CNB, the final malignancy results were greater in Group AUS (65%, 33/51) than Group FLUS (14.3%, 13/91; p<0.001), and there were more surgical candidates in Group AUS (57.8%, 46/84) than Group FLUS (19.6%, 21/107; p<0.001). CNB showed 95.8% diagnostic accuracy for identifying malignancies and 19.4% inconclusive readings. Malignant US findings were seen more frequently in Group AUS (76.5%, 39/51) than Group FLUS (52.7%, 48/91; p=0.007). Malignant CNB readings were statistically more frequent in Group AUS (49.2%, 41/84) than Group FLUS (9.4%, 10/107; p<0.001), and benign readings were statistically more frequent in Group FLUS (58.9%, 63/107) than Group AUS (28.6%, 24/84; p<0.001). CONCLUSIONS US-guided CNB demonstrated that Group AUS showed a higher risk of malignancy, of becoming surgical candidates, of having malignant US findings, and of having malignant CNB readings than Group FLUS. Further management guidelines for Group AUS should differ from Group FLUS.

[1]  Darya Chudova,et al.  Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. , 2012, The New England journal of medicine.

[2]  M. Prasad,et al.  Thyroid follicular lesion of undetermined significance: Evaluation of the risk of malignancy using the two‐tier sub‐classification , 2012, Diagnostic cytopathology.

[3]  D. Na,et al.  Core-needle biopsy is more useful than repeat fine-needle aspiration in thyroid nodules read as nondiagnostic or atypia of undetermined significance by the Bethesda system for reporting thyroid cytopathology. , 2012, Thyroid : official journal of the American Thyroid Association.

[4]  A. Renshaw,et al.  The atypia of undetermined significance/follicular lesion of undetermined significance:malignant ratio , 2012, Cancer cytopathology.

[5]  J. Krane,et al.  The atypical thyroid fine‐needle aspiration: Past, present, and future , 2012, Cancer cytopathology.

[6]  D. Na,et al.  Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort , 2012, European Radiology.

[7]  D. Clark,et al.  Spectrum of Risk of Malignancy in Subcategories of ‘Atypia of Undetermined Significance’ , 2011, Acta Cytologica.

[8]  A. Renshaw.  Subclassification of atypical cells of undetermined significance in direct smears of fine‐needle aspirations of the thyroid , 2011, Cancer cytopathology.

[9]  E. Marqusee,et al.  Usefulness of diagnostic qualifiers for thyroid fine-needle aspirations with atypia of undetermined significance. , 2011, American journal of clinical pathology.

[10]  L. Morelli,et al.  Subclassification of the “Grey Zone” of Thyroid Cytology; A Retrospective Descriptive Study with Clinical, Cytological, and Histological Correlation , 2011, Journal of thyroid research.

[11]  E. Marqusee,et al.  Clinical outcome for atypia of undetermined significance in thyroid fine-needle aspirations: should repeated fna be the preferred initial approach? , 2011, American journal of clinical pathology.

[12]  Dong Gyu Na,et al.  Ultrasonography and the Ultrasound-Based Management of Thyroid Nodules: Consensus Statement and Recommendations , 2011, Korean journal of radiology.

[13]  Z. Baloch,et al.  Fine‐needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow‐up according to National Cancer Institute (NCI) recommendations , 2010, Diagnostic cytopathology.

[14]  E. Stelow,et al.  Malignancy risk for fine-needle aspiration of thyroid lesions according to the Bethesda System for Reporting Thyroid Cytopathology. , 2010, American journal of clinical pathology.

[15]  A. Renshaw.  Should “atypical follicular cells” in thyroid fine‐needle aspirates be subclassified? , 2010, Cancer cytopathology.

[16]  R. Seethala,et al.  Contribution of molecular testing to thyroid fine‐needle aspiration cytology of “follicular lesion of undetermined significance/atypia of undetermined significance” , 2010, Cancer cytopathology.

[17]  R. Udelsman,et al.  The Bethesda thyroid fine-needle aspiration classification system: year 1 at an academic institution. , 2009, Thyroid : official journal of the American Thyroid Association.

[18]  E. Cibas,et al.  The Bethesda System for Reporting Thyroid Cytopathology , 2009, Springer International Publishing.

[19]  L. Layfield,et al.  Implications of the proposed thyroid fine‐needle aspiration category of “follicular lesion of undetermined significance”: A five‐year multi‐institutional analysis , 2009, Diagnostic cytopathology.

[20]  Juan Rosai,et al.  Diagnostic terminology and morphologic criteria for cytologic diagnosis of thyroid lesions: A synopsis of the National Cancer Institute Thyroid Fine‐Needle Aspiration State of the Science Conference , 2008, Diagnostic cytopathology.

[21]  Jeong Hyun Lee,et al.  Benign and malignant thyroid nodules: US differentiation--multicenter retrospective study. , 2008, Radiology.

[22]  A. Gawande,et al.  Long‐term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation , 2007, Cancer.

[23]  D. Burstein,et al.  Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. , 2001, Thyroid : official journal of the American Thyroid Association.

[24]  M. Gapany.  Role of core needle biopsy and ultrasonographic finding in management of indeterminate thyroid nodules , 2012 .

[25]  S. Raab.  The Indeterminate Thyroid Fine-Needle Aspiration: Experience From an Academic Center Using Terminology Similar to That Proposed in the 2007 National Cancer Institute Thyroid Fine Needle Aspiration State of the Science Conference , 2010 .